MedTrace Logo

The Perceived Efficiency and Acceptability of Remote Real-time Health Monitoring System in Elderly Residential Setting and Community Isolation Facility

NCT05302440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-07-05

Study results available
· View outcomes & findings →

Summary

The study has 3 primary research questions and 6 secondary research questions targeting care staff in the setting of residential care homes for the elderly. The 3 primary research questions are:

1. Will care staff perceive the remote real-time health monitoring system with ring-like sensor as efficient?
2. Will the system facilitate any early detection of abnormal vital signs?
3. Will the system facilitate early delivery of medical support?

The 6 secondary research questions are:
4. What are the numbers of hospital admissions and further medical assistance due to the adoption of the system?
5. Will the system reduce the stress level of the care staff?
6. What are the perceived benefits and acceptability of the care staff towards the system?
7. What should be considered when developing the evaluation framework for the adaption of the system in elderly residential setting?
8. Are there any barriers and difficulties in the set-up of the system?
9. What are the concerns in choosing wireless or cable connection for the monitoring device?

Conditions

  • Technology

Interventions

DEVICE

remote real-time health monitoring system with ring-like sensor

The remote monitoring system will constantly record the temperature, pulse and SpO2 of the residents wearing the equipment. When the staff find abnormal vital signs, they will provide further medical assistance. All care staff who manage the system will be complete a very brief survey (1-minute) after each work shift for 14 days.

Sponsors & Collaborators

  • Haven of Hope Hospital

    collaborator OTHER

  • The Social Innovation and Entrepreneurship Development Fund, Hong Kong

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Yee Tak Cheung, PhD · The University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2022-05-09
Completion
2022-05-09
FDA Device
Yes

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05302440 on ClinicalTrials.gov